Preprint
Article

This version is not peer-reviewed.

Association of the COL27A1 rs946053 and TNC rs2104772s with Tendinopathies: Case-Control Study in High-Level Athletes

A peer-reviewed article of this preprint also exists.

Submitted:

26 June 2025

Posted:

30 June 2025

You are already at the latest version

Abstract
Background/Objectives: Increased risk of developing tendinopathies in athlete population has led to investigations of several genes associated with tendon properties, suggesting some individuals have greater genetic predisposition for developing tendinopathies. The main purpose of this study was to investigate how the functional polymorphisms within the COL5A1, COL27A1 and TNC genes impact risk of developing tendinopathies in Croatian high-level athletes. Methods: For this case-control genetic study we have recruited sixty-three high-level athletes with diagnosed tendinopathies and ninety-two asymptomatic healthy controls, all being unrelated Caucasians. Participants were genotyped for three single nucleotide polymorphisms (SNP) within COL5A1, COL27A1 and TNC genes using the pyrosequencing method. Results: TNC rs2104772 TT (P=0.0089) and T-T-T haplotype (P=0.0234) constructed of rs12722, rs946053 and rs2104772 were significantly over-represented in cases versus controls, implicating predisposition for tendinopathies. COL27A1 rs946053 GG (P=0. 0118) and G-A-C haplotype (P=0.0424) constructed of rs12722, rs946053 and rs2104772 were significantly over-represented in controls implicating protective role. Conclusions: These results further support associations between functional polymorphisms within the COL27A1 and TNC genes and risk of tendinopathies in high-level athletes. Further research is needed to replicate these results in various populations and in larger cohorts.
Keywords: 
;  ;  ;  ;  ;  ;  

1. Introduction

Regular physical activity benefits those who participate, even though it also increases injury risk. Sedentary lifestyle usually led by recreational athletes prior to returning to a regular sport activity is often underlying cause of sudden overuse injuries that affect tendons, while tendon ruptures and tendinopathies are serious injuries affecting athletes, causing pain and disfunction and adding to the delay in recovery and prolonging return to competing for professional athletes [1,2]. Tendon role is to facilitate smooth joint movements, but through that process tendons sustain large strain when transmitting force from muscle to bone. Achilles tendon ruptures are higher in males than in females, with ratio ranging from 2:1 to 12:1 [3,4], just like the prevalence of Achilles tendinopathy seems to be increasing through the population, ranging from 10% in general population to up to 50% within professional athletes [5,6]. Tendinopathies are common overuse injuries associated with sports, in acute or chronic states, mostly affecting Achilles, patellar, rotator cuff and forearm extensor tendons [7]. Different extrinsic and intrinsic factors have been reported. Extrinsic factors include occupation, sport, physical load, training errors and some other factors, while intrinsic factors include age, gender, nutrition, anatomical variants, joint laxity and genetic susceptibility [8,9]. Tendons are highly ordered in structure, made of tightly packed bundles of fibrils. Collagen is the most abundant protein in tendons making up to 80% of total dry mass. Glycoproteins, proteoglycans, such as elastin and tenascin C and other proteins make rest of the tendon dry mass. Type I collagen makes most of the collagen dry mass, while type III and type V collagen and few others add to the rest [10]. Type V collagen, encoded by the COL5A1 gene, regulates diameter of type I collagen fibrils, consists of the triple α1 chains and appears in tissues where collagen type I is expressed [11,12]. The COL5A1 gene is located on the long arm of chromosome 9 (9q32-q34). Single nucleotide polymorphisms (SNPs) occur normally throughout the genome, on average in every 100-300 base pairs and add up to 90% of the changes within the genome, resulting in roughly 4 to 5 million SNPs. Several SNPs have been found and associated with Achilles tendon injuries, anterior cruciate ligament rupture and range of motion measurements [13,14,15,16,17]. Just like the COL5A1, the TNC gene is too located on the chromosome 9, 19.6 Mbp upstream of the COL5A1, encoding the tenascin C glycoprotein, expressed in highly constrained manner in embryonic tissues, as well as in adult tissues during remodeling and would healing [18,19]. The extracellular matrix of musculoskeletal tissues that transmit mechanical forces and are exposed to high stress have high levels of TNC expression [20]. TNC glycoprotein plays an important role in regulation cell-matrix interactions. Polymorphisms within the TNC gene have been associated with Achilles tendinopathy [21,22], allergic diseases [23] and adult asthma [24]. Another gene in the proximity of TNC and COL5A1 may be of interest. The COL27A1 gene encodes the homotrimeric type XXVII fibrillar collagen, that provides structural framework and tensile strength and is highly conserved in vertebrates [25,26]. The risk of Achilles tendinopathy was significantly associated for the haplotype consisting of the TNC and COL27A1 sequence variants in Caucasian population [27]. The aim of this study was to investigate a possible association between the COL5A1 rs12722, COL27A1 rs946053 and TNC rs2104772 polymorphisms and tendinopathies in Croatian athletes. The hypothesis of this study is that polymorphisms are associated with the incidence of tendinopathy occurrence and that there will be a difference in genotype frequency and haplotypes between affected and athletes that were not affected.

2. Materials and Methods

Participants

One hundred and fifty-five participants were recruited between 2016 and 2017 and included in a case-control genetic association study. All participants are self-reported unrelated Caucasians and physically active athletes of various sports. The Achilles tendinopathy group (TEN) had clinically diagnosed Achilles tendinopathy, with symptoms including progressive pain, tendon swelling or changes of the lesions thickness and sensitivity to palpation. TEN group consisted of 63 participants (47 male and 16 female, average age 32 years), most being high level competing athletes in their prospective sports, with 3-7 coach supervised trainings per week. TEN participants were recruited in Orthopedic Clinic by their team medical doctor, orthopedic surgeon. Control group (CON) consisted of 92 participants (72 male and 20 female, average age 39.0 years) that were done with their active athlete career and have self-reported not having tendinopathies during their active competing career. This study was approved by the Ethics Committee of the School of Medicine, University of Zagreb, Croatia and by the Ethics Committee of the Faculty of Kinesiology, University of Zagreb, Croatia. All participants have provided a biological sample and given written informed consent.

Genotyping

Genomic deoxyribonucleic acid (DNA) was extracted from the oral epithelial cells using QIAamp DNA kit (Qiagen, Germantown, MD, USA). Polymerase chain reaction (PCR) amplification was conducted using COL5A1 rs12722, COL27A1 rs946053 and TNC rs2104772 T>A specific primer pairs (Metabion, Planegg/ Steinkirchen, Germany) and PyroMark PCR Kit (Qiagen, Germantown, MD, USA). Amplified fragments were sequenced by pyrosequencing method (PyroMark Q24, Qiagen, Germantown, MD, USA) according to the manufacturer’s protocol and analyzed by PyroMark Q24 software (Qiagen, Germantown, MD, USA).

Statistical analysis

Allelic, genotypic and haplotype differences were anaalysed using an odds ratio method, Statcalc program (AcaStat software, Orange County, FL, USA). When P was P<0.05 it was considered being a statistically significant difference. For haplotype analysis we used Phase software (Matthew Stephens Laboratory, University of Chicago, IL, USA). The Hardy–Weinberg equilibrium analysis was performed using Genetics package for R software. In this study we used groups similar in size to previously reported studies [13,15,28] investigating genotype effects on various soft-tissue injuries, as those group sizes proved to be large enough to detect significant results. The Bonferroni correction is considered too conservative [29], so it was not applied in this study. P values were adjusted for false discovery rate (FDR) using Benjamini-Hochberg procedure for adjusted P value. It was applied for each genotypic, allelic and haplotype separately.

3. Results

Participants entering this study were divided in two groups: TEN group with diagnosed tendinopathy and CON group with no prior self-reported tendinopathy injuries during their active competing period in their professional career. It is important to notice that CON group has significantly higher weight and body mass index (BMI) and is chronologically older than TEN group, which is explained by the changes in lifestyle once professional athletes are retired. Average height of both TEN and CON group is comparable, and for the purpose of this study it was assumed that weight and BMI of the CON group at the peak point of retired athletes’ career were comparable to TEN group. Data presented in Table 1. are matched for height, gender and ethnicity, not for BMI and weight as explained earlier.
Genotype frequencies were significantly different between TEN and CON groups. GG genotype of rs946053 was over-represented in controls when compared with cases, therefore classified as protective, while TT genotype of rs2104772 T>A was significantly over-represented in TEN group and is associated with the higher risk of tendinopathies. None of the rs12722 genotypes has any significant relevance in our cohort. In the similar manner, allelic frequencies were significantly different between two groups. G allele of rs946053 and rs2104772 A allele where significantly over-represented in controls and determined as protection, while T alleles of both rs946053 and rs2104772 were significantly over-represented in cases when compared to controls, so they are considered a predisposition for tendinopathies development. T and C allele of rs12722 did not show associations. All polymorphisms conformed to the Hardy-Weinberg equilibrium (HWE) in both cases and control group (Table 2).
Haplotypes of all possible combinations of SNPs rs12722, rs946053 and rs2104772 T>A were constructed and analysed, and after correcting for FDR, T-T-T haplotype was considered as predisposition for development of tendinopathies, while G-A-C haplotype was considered as protective, presented in Table 3.

4. Discussion

Our understanding of the molecular mechanisms underlying soft tissue injuries is still limited. Different candidate gene variants are researched daily. Some of the previously reported variants have been successfully replicated in another populations, while some have stayed significant for one population only. Considering previous studies conducted on other populations, this study has investigated further variations within COL5A1, COL27A1 and TNC genes and related risks of developing tendinopathies. The main finding of our study conducted in a cohort of Croatian competing athletes suggested that TT genotype of TNC rs2104772 T>A and T-T-T haplotype constructed of COL5A1 rs12722, COL27A1 rs946053 and TNC rs2104772 T>A had a significant association with the risk of developing tendinopathies. On the other hand, GG genotype of COL27A1 rs946053 suggested protection of developing tendinopathies, as well as G-A-C haplotype constructed of COL5A1 rs12722, COL27A1 rs946053 and TNC rs2104772 T>A.
Many previous studies have suggested that genetic factors with the strongest evidence of association involved polymorphisms within COL5A1, COL27A, TNC genes, as well as matrix metaloproteinase-3 (MMP3) and estrogen-related receptor beta (ESRRB) [14,15,16,17,21,27,30,31].
September et al. investigated COL5A1 gene and showed that individuals with CC genotype of rs12722 were predisposed to Achilles tendon injuries in South African and Australian population [14]. Following these findings, Brown et al. investigated COL5A1 rs12722 further in the British cohort, but similarly to our own, in European cohort CC genotype was not significant in AT pathology. Although COL5A1 rs12722 was not significantly overrepresented in AT group by itself, three inferred allele combinations constructed of rs12722, rs3196378 and rs71746744 within the COL5A1 gene were identified as risk modifiers [32]. Study conducted on the population of young academic soccer players connected CC genotype and C-allele carriers for COL5A1 rs12722 with predisposition to more soft tissue and ligament injuries, indicating that these associations depend on maturity status due to phase of physical development of these tissues [33]. Other than age, some other factors should be taken in account when identifying risk connected to genetic variants such as gender and ethnicity. Figueiredo et al. in their study on rotator cuff tear showed that C/T haplotype for COL5A1 rs3196378 and rs11103544 has protective effect but only for males [34].
Contrary to these studies, Heffernan et al. observed large cohort of elite rugby players and associate C allele of rs12722 and rs3196378 with protective properties against tendon injuries, lower incidence of muscle cramping, and also reported generally greater frequency of allele C in players compared to control group [35].
Saunders et al. genotyped Australian and South African population for four polymorphisms within the COL27A1 gene (rs946053, rs753085, rs1249744, rs4143245) and three within TNC gene (rs2104772, rs1330363, rs13321) resulting in the finding that the GCA haplotype (rs946053-rs13321-rs2104772) occurred significantly more frequent in TEN population [27]. Continuing in that direction, they investigated further implications of variants in several genes including COL27A1 and TNC, as well as IL-6, IL-1β and CASP8, concluding there are subtle effects on protein signaling, interactions or alternate splicing that may be contributing to Achilles tendon pathologies [22].
Further research focused on a whole-exome sequencing approach, where Gibbon et al. sequenced ten healthy controls and ten patients with Achilles tendinopathy, by using a platform which included coverage of the untranslated regions as well as miRBase miRNA genes. Results showed four variants in TNC (rs1061494, rs1138545, rs2104772 and rs1061495) and three variants in the upstream COL27A1 gene (rs2567706, rs2241671 and rs2567705) which were genotyped in both Achilles tendinopathy group and anterior cruciate ligament group. TNC gene inferred haplotype was too associated with Achilles tendinopathy risk [28].
Inelastic structure of tendons allows the resistance to very high forces. Capacity to withstand heavy loads before failure depends on the cross-sectional area and length, but excessive loading and tensile strains will in the end often result in tendinopathies. Extrinsic factors include overuse linked to sports activities, errors in training programme, faulty equipment and even weather conditions, such as sport activities performed in cold weather are also accounted as risk factors. Use of the Fluroquinolone based antibiotics have been proven to impact tendinopathies [36]. On the other hand, intrinsic factors will take under consideration several pathological conditions, for example association between Achilles tendinopathy and obesity/weight, genetic aspects as well as age, gender and height related factors of tendinopathy [37].
Professional athletes will have the more significant risk of developing tendinopathies mainly due to overuse by being involved in high-performance sports, with the additional negative effect for those being exposed to wide range of temperatures in sports that take place outdoors. Tendinopathy is increasing in prevalence in professional athletes, as well as in recreational athletes, accounting for substantial part of all sports injuries. Mostly affected are Achilles and patellar tendon, rotator cuff and extensor carpi radialis brevis, commonly known as tennis elbow tendon [38,39].
While tendinopathies are more manageable, overuse can lead to ruptures. Achilles tendon ruptures ended careers of up to 30% NBA basketball players, with their return to sports being as low as 61%. Athletes of similar movements including sudden stops, fast changes in direction and explosive acceleration are all putting an increased stress on lower body tendon complexes. Once injury occurs, most of the athletes will still find a way to return to the competitive sports, but their careers will be shorter and their performance will be decreased compared to their previous baseline [40,41]. In 2015. Goodlin at al. performed an interesting pilot program on fourteen triathletes, where they were genotyped and educated about their genetic make-up and personal risk profile. Participants responded positive, found it informative and it was reported that most acted upon their genetic results [42].

5. Conclusions

For professional, as well as for recreational athletes, knowledge of their genetic risk factors could prove to be useful, as it contributes to risk of soft tissue injuries. Additional knowledge of risk status could be used in modifying extrinsic factors and taking pre-emptive actions through more thorough conditional training, by incorporating more resting periods paired with preventive exercises to reduce risk of injury occurrence. Genetics of sports injuries is still very limited mainly in size of the cohorts that are being investigated, so every piece of additional genetic results of different populations adds to the bigger picture.

Author Contributions

Conceptualization, G.V. and N.Š-B..; methodology, G.V.; software, I.D-O. and G.L.; validation, N.Š-B, S.J. and D.K.; formal analysis, I.D-O. and G.L.; investigation, G.V. and N.Š-B.; resources, S.J.; data curation, I.D-O.; writing—original draft preparation, G.V. and N.Š-B.; writing—review and editing, S.J. and D.K.; visualization, G.V. and N.Š-B; supervision, S.J., G.L. and D.K.; project administration, N.Š-B. and I.D-O.; funding acquisition, G.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding. The research was supported by the authors.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Medical ethics committee of the School of Medicine, University of Zagreb (380-59-10106-18-111/100, 24.05.2018.) and by the Ethics committee of the Faculty of Kinesiology, University of Zagreb (27.04.2016.).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study is available upon request to the corresponding author. Data was not made publicly available to maintain patient privacy.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
COL     collagen
SNP     single nucleotide polymorphisms 
TNC     tenascin C
TEN     tendinopathy
DNA    deoxyribonucleic acid 
PCR     polymerase chain reaction 
FDR     false discovery rate 
CON    control group
BMI     body mass index
HWE    Hardy-Weinberg equilibrium 
MMP 3   matrix metaloproteinase-3 
ESRRB     estrogen-related receptor beta 
MiRNA   micro ribonucleic acid   

References

  1. Kim, S.K.; Roos, T.R.; Roos, A.K.; Kleimeyer, J.P.; Ahmed, M.A.; Goodlin, G.T.; Fredericson, M.; Ioannidis, J.P.A.; Avins, A.L.; Dragoo, J.L. Genome-wide association screens for Achilles tendon and ACL tears and tendinopathy. PLoS One 2017, 12, 3. [CrossRef]
  2. Ljungqvist, A.; Schwellnus, M.P.; Bachl, N.; Collins, M.; Cook J.; Khan, K.M.; Maffulli, N.; Pitsiladis, Y.; Riley, G.; Golspink, G.; et al. International Olympic Committee Consensus Statement: Molecular Basis of Connective Tissue and Muscle Injuries in Sport. Clin Sports Med 2008, 27, 231–239. [CrossRef]
  3. Vosseller, J.T.; Scott, J.E.; Levine, D.S.; Kennedy, J.G.; Elliott, A.J.; Deland, J.T.; Roberts, M.M.; O’Malley M.J. Achilles tendon rupture in women. Foot Ankle Int 2013, 34, 49–53. [CrossRef]
  4. Hess, G.W. Achilles tendon rupture: A review of etiology, population, anatomy, risk factors, and injury prevention. Foot Ankle Spec 2010, 3, 29-32. [CrossRef]
  5. Kujala U.M.; Sarna, S.; Kaprio, J. Cumulative Incidence of Achilles Tendon Rupture and Tendinopathy in Male Former Elite Athletes. Clin J Sport Med 2005, 15, 133-135. [CrossRef]
  6. de Jonge, S.; van den Berg, C.; de Vos, R.J.; van der Heide, H.J.L.; Weir, A.; Verhaar, J.A.N.; Bierma-Zeimstra, S.M.A.; Tol, J.L. Incidence of midportion Achilles tendinopathy in the general population. Br J Sports Med 2011, 45, 1026–1028. [CrossRef]
  7. Longo, U.G.; Loppini, M.; Margiotti, K.; Salvatore, G.; Berton, A.; Khan, W.S.; Maffulli, N.; Denaro, V. Unravelling the Genetic Susceptibility to Develop Ligament and Tendon Injuries. Curr Stem Cell Res Ther 2015, 10, 56–63. [CrossRef]
  8. Meeuwisse, W.H. Assessing Causation in Sport Injury: A Multifactorial Model. Clinical Journal of Sport Medicine 1994, 4, 166–170.
  9. Riley, G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology 2004, 43, 131–142. [CrossRef]
  10. Silver, F.H.; Freeman, J.W.; Seehra, G.P. Collagen self-assembly and the development of tendon mechanical properties. J Biomech 2003, 36, 1529–1553. [CrossRef]
  11. Mizuno, K.; Adachi, E.; Imamura, Y.; Katsumata, O.; Hayashi, T. The fibril structure of type V collagen triple-helical domain. Micron 2001, 32, 317–323. [CrossRef]
  12. Niyibizi, C.; Eyre, D.R. Structural characteristics of cross-linking sites in type V collagen of bone Chain specificities and heterotypic links to type I collagen. Eur. J. Biochem 1994, 224, 943–950. [CrossRef]
  13. Mokone, G.G; Schwellnus, M.P.; Noakes, T.D.; Collins, M. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports 2006, 16, 19–26. [CrossRef]
  14. September, A.V.; Cook, J.; Handley, C.J.; van der Merwe, L.; Schwellnus, M.P.; Collins, M. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med 2009, 43, 357–365. [CrossRef]
  15. Posthumus, M.; September, A.V.; O’Cuinneagain, D.; van der Merwe, W.; Schwellnus, M.P.; Collins, M. The COL5A1 gene is associated with increased risk of anterior cruciate ligament ruptures in female participants. American Journal of Sports Medicine 2009, 37, 2234–2240. [CrossRef]
  16. Collins, M.; Posthumus, M.; Schwellnus, M.P. The COL1A1 gene and acute soft tissue ruptures. Br J Sports Med 2010, 44, 1063–1064. [CrossRef]
  17. Brown, J.C.; Miller, C.J.; Schwellnus, M.P.; Collins, M. Range of motion measurements diverge with increasing age for COL5A1 genotypes. Scand J Med Sci Sports 2011, 21, 266-272. [CrossRef]
  18. Jones, F.S.; Jones, P.L. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Developmental Dynamics 2000, 218, 235–259. [CrossRef]
  19. Jones, P.L.; Jones, F.S. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biology 2000, 19, 581–596. [CrossRef]
  20. Järvinen, T.A.H.; Józsa, L.; Kannus, P.; Järvinen, T.L.N.; Hurme, T.; Kvist, M.; Pelto-Huikko, M.; Kalimo, H.; Järvinen, M. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci 2003, 116, 857-866. [CrossRef]
  21. Mokone, G.G.; Gajjar, M.; September, A.V.; Schwellnus, M.P.; Greenberg, J.; Noakes, T.D.; Collins, M. The Guanine-Thymine Dinucleotide Repeat Polymorphism Within the Tenascin-C Gene is Associated With Achilles Tendon Injuries. American Journal of Sports Medicine 2005, 33, 1016–1021. [CrossRef]
  22. Saunders, C.J.; van der Merwe, L.; Cook, J.; Handley, C.J.; Collins, M.; September, A.V. Extracellular matrix proteins interact with cell-signaling pathways in modifying risk of Achilles tendinopathy. Journal of Orthopaedic Research 2015, 33, 898–903. [CrossRef]
  23. Orsmark-Pietras, C.; Melén, E.; Vendelin, J.; Bruce, S.; Laitinen, A.; Laitinen, L.A.; Lauener, R.; Riedler, J.; von Mutius, E.; Doekes, G.; et al. Biological and genetic interaction between Tenascin C and Neuropeptide S receptor 1 in allergic diseases. Hum Mol Genet 2008, 17, 1673–1682. [CrossRef]
  24. Matsuda, A.; Hirota, T.; Akahoshi, M.; Shimizu, M.; Tamari, M.; Miyatake, A.; Takahashi, A.; Nakashima, K.; Takahashi, N.; Obara, K.; et al. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum Mol Genet 2005, 14, 2779–2786. [CrossRef]
  25. Pace, J.M.; Corrado, M.; Missero, C.; Byers, P.H. Identification, characterization and expression analysis of a new fibrillar collagen gene, COL27A1. Matrix Biology 2003, 22, 3-14. [CrossRef]
  26. Boot-Handford, R.P.; Tuckwell, D.S.; Plumb, D.A.; Farrington Rock, C.; Poulsom, R. A novel and highly conserved collagen (proα1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. Journal of Biological Chemistry 2003, 278, 31067–31077. [CrossRef]
  27. Saunders, C.J.; van der Merwe, W.; Posthumus, M.; Cook, J.; Handley, C.J.; Collins, M.; September, A.V. Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations. Journal of Orthopaedic Research 2013, 31, 632–637. [CrossRef]
  28. Gibbon, A.; Saunders, C.J.; M. Collins, M.; Gamieldien, J.; September, A.V. Defining the molecular signatures of Achilles tendinopathy and anterior cruciate ligament ruptures: A whole-exome sequencing approach. PLoS One 2018, 13, e0205860. [CrossRef]
  29. Nyholt, D.R. A Simple Correction for Multiple Testing for Single-Nucleotide Polymorphisms in Linkage Disequilibrium with Each Other. Am J Hum Genet 2004, 74, 765–769. [CrossRef]
  30. Vaughn, N.H.; Stepanyan, H.; Gallo, R.A.; Dhawan, A. Genetic factors in tendon injury: A systematic review of the literature. Orthop J Sports Med 2017, 5, 2325967117724416. [CrossRef]
  31. Briški, N.; Vrgoč, G.; Knjaz, D.; Janković, S.; Ivković, A.; Pećina, M.; Lauc, G. Association of the matrix metalloproteinase 3 (MMP3) single nucleotide polymorphisms with tendinopathies: case-control study in high-level athletes,” Int Orthop 2021, 45, 1163–1168. [CrossRef]
  32. Brown, K.L; Seale, K.B.; El Khoury, L.Y.; Posthumus, M.; Ribbans, W.J.; Raleigh, S.M.; Collins, M.; September, A.V. Polymorphisms within the COL5A1 gene and regulators of the extracellular matrix modify the risk of Achilles tendon pathology in a British case-control study. J Sports Sci 2017, 35, 1475–1483. [CrossRef]
  33. Hall, E.C.R.; Baumert, P.; Larruskain, J.; Gil, S.M.; Lekue, J.A.; , Rienzi, E.; Moreno, S.; Tannure, M.; Murtagh, C.F.; Ade, J.D.; Squires, P.; et al. The genetic association with injury risk in male academy soccer players depends on maturity status. Scand J Med Sci Sports 2022, 32, 338–350. [CrossRef]
  34. Figueiredo, E.A.; Loyola, L.C.; Belangero, P.S.; Campos Ribeiro-Dos-Santos, Â.K.; Emanuel Batista Santos, S.; Cohen, C.; Wajnsztejn, A.; Martins de Oliveira, A.; Smith, M.C.; Pochini, A.C.; et al. Rotator Cuff Tear Susceptibility Is Associated With Variants in Genes Involved in Tendon Extracellular Matrix Homeostasis. Journal of Orthopaedic Research 2020, 38, 192–201. [CrossRef]
  35. Heffernan, S.M; Kilduff, L.P.; Erskine, R.M.; Day, S.H.; Stebbings, G.K.; Cook, C.J.; Raleigh, S.M.; Bennett, M.A.; Wang, G.; Collins M,: et al. COL5A1 gene variants previously associated with reduced soft tissue injury risk are associated with elite athlete status in rugby. BMC Genomics 2017, 18, 820. [CrossRef]
  36. van der Linden, P.D.; van de Lei, J.; Nab, H.W.; Knol, A.; Stricker, B.H. Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol 1999, 48, 433–437. [CrossRef]
  37. Abate, M.; Silbernagel, K.G.; Siljeholm, C.; Di Iorio, A.; De Amicis, D.; Salini, V.; Werner, S.; Paganelli, R. Pathogenesis of tendinopathies: inflammation or degeneration? Arthritis Res Ther 2009, 11, 235. [CrossRef]
  38. Ackermann, P.W.; Renström, P. Tendinopathy in Sport. Sports Health 2012, 4, 193–201. [CrossRef]
  39. Lemme, N.J; Li, N.Y.; DeFroda, S.F.; Kleiner, J.; Owens, B.D. Epidemiology of Achilles Tendon Ruptures in the United States: Athletic and Nonathletic Injuries From 2012 to 2016. Orthop J Sports Med 2018, 6, 2325967118808238. [CrossRef]
  40. Khalil, L.S.; Jildeh, T.R.; Tramer, J.S.; Abbas, M.J.; Hessburg, L.; Mehran, N.; Okoroha, K.R. Effect of Achilles Tendon Rupture on Player Performance and Longevity in National Basketball Association Players. Orthop J Sports Med 2020, 8, 2325967120966041. [CrossRef]
  41. Hodgens, B.H; Geller, J.S.; Rizzo, M.G.; Munoz, J.; Kaplan, J.; Aiyer, A. Performance Outcomes After Surgical Repair of Achilles Tendon Rupture in the Women’s National Basketball Association. Orthop J Sports Med 2021, 9, 23259671211030473. doi: 10.1177/23259671211030473.
  42. Goodlin, G.T.; Roos, A.K.; Roos, T.R.; Hawkins, C.; Beache, S.; Baur, S.; Kim, S.K. Applying personal genetic data to injury risk assessment in athletes. PLoS One 2015, 10, e0122676. [CrossRef]
Table 1. General characteristics of the tendinopathy group and control group.
Table 1. General characteristics of the tendinopathy group and control group.
TEN (n=63) Controls (n=92) P-value
Age (years) 32.1 ± 12.8 39.0 ± 11.4 0.006
Height (cm) 180.5 ± 8.8 179.8 ± 9.6 0.6454
Weight (kg) 79.4 ± 14.9 84.6 ± 15.4 0.0381
BMI (kg/m2) 24.1 ± 3.6 26.0 ± 3.3 0.009
Ethnicity (Caucasian) 100% (63) 100% (92) 1.0000
gender (% male) 75% (47) 78% (92) 0.6639
Ethnicity and gender are represented as a percentage, the remaining variables are expressed as a mean ± standard deviation. Significant P-values are in bold. Age, height and weight are self-reported values in time of the recruitment.
Table 2. Allele and genotype frequency.
Table 2. Allele and genotype frequency.
COL5A1 Allele frequency
SNP C>T TEN CON
rs12722 n=63 n=92 p FDR OR 95% CI Association
1 C 42.1% (53) 45.1% (83) 0.5957 0.8835 0.5590 - 1.3962 none
2 T 57.9% (73) 54.9% (101) 0.5957 1.1319 0.7162 - 1.7888 none
Genotype frequency
SNP C>T TEN CON
rs12722 n=63 n=92 p FDR OR 95% CI Association
11 CC 14.3% (9) 21.7% (20) 0.2456 0.6000 0.2533 - 1.4210 none
12 CT 55.6% (35) 46.7% (43) 0.2816 14.244 0.7481 - 2.7121 none
22
TT
30.1% (19)
31.6% (29)
0.8570
0.9381
0.4682 - 1.8795
none
HWE 0.267
COL27A1 Allele frequency
SNP G>T TEN CON
rs946053 n=63 n=92 p FDR OR 95% CI Association
1 G 43.7% (55) 56.5% (104) 0.0264 0.0264 0.5959 0.3773 - 0.9412 protection
2 T 56.3% (71) 43.5% (80) 0.0264 0.0264 1.6782 1.0625 - 2.6506 Predisposition
Genotype frequency
SNP G>T TEN CON
rs946053 n=63 n=92 p FDR OR 95% CI Association
11 GG 14.3% (9) 32.6% (30) 0.0118 0.0354 0.3444 0.1503 - 0.7895 protection
12 GT 58.7% (37) 47.8% (44) 0.1829 15.524 0.8127 - 2.9656 none
22 TT 27% (17) 19.6% (18) 0.279 15.193 0.7118 - 3.2428 none
HWE 0.124
TNC Allele frequency
SNP T>A TEN CON
rs2104772 n=63 n=92 p FDR OR 95% CI Association
1 T 61.1% (77) 48.4% (89) 0.0276 0.0276 1.6774 1.0586 - 2.6579 predisposition
2 A 38.9% (49) 51.6% (95) 0.0276 0.0276 0.5962 0.3762 - 0.9447 protection
Genotype frequency
SNP T>A TEN CON
rs2104772 n=63 n=92 p FDR OR 95% CI Association
11 TT 42.9% (27) 22.8% (21) 0.0089 0.0267 25.357 1.2628 - 5.0918 predisposition
12 TA 36.5% (23) 51.1% (47) 0.0745 0.5505 0.2857 - 1.0608 none
22 AA 20.6% (13) 26.1% (24) 0.4351 0.7367 0.3402 - 1.5869 none
HWE 0.066
Allele and genotype frequencies are expressed as percentage with the number of participants (n) in parentheses. Results that have been classified as significant by the P-value (P<0.05) are in bold and have been additionally checked for false discovery rate (FDR), using Benjamini-Hochberg adjusted P value. OR- odds ratio. 95% CI – 95% confidence interval.
Table 3. Haplotype frequency.
Table 3. Haplotype frequency.
Hap code Haplotype CON TEN p FDR OR 95% CI Association
1 G - A - T 16 5 0.1038 0.4339 0.1547 - 1.2166 none
2 G - A - C 25 8 0.0424 0.0424 0.4310 0.1880 - 0.9900 protection
3 G - T - T 32 21 0.8678 0.9500 0.5193 - 1.7380 none
4 G - T - C 31 21 0.9666 0.9871 0.5379 - 1.8114 none
5 T - A - T 42 30 0.7729 1.0565 0.6186 - 1.8046 none
6 T - A - C 11 6 0.6441 0.7864 0.2831 - 2.1843 none
7 T - T - T 11 17 0.0234 0.0424 2.453 1.107 - 5.434 predisposition
8 T - T - C 16 18 0.1219 1.7500 0.8556 - 3.5792 none
Results that have been classified as significant by the P-value (P<0.05) are in bold and have been additionally checked for false discovery rate (FDR), using Benjamini-Hochberg adjusted P value. OR- odds ratio. 95% CI – 95% confidence interval.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated